James J. Mulé
DirectoratCG Oncology· In proxies 2024–2025
James J. Mulé sits on 2 public boards.
Boards1
- CG OncologyDirector · 7 yr on the boardIndependent—Paid as an executive
Board seats come from each company's latest proxy statement.
Experience
- CG OncologyPublic company · 2 yr
- Director2024 – Present · 2 yrStock in role +72%
- Fulgent Genetics, Inc.Public company · 4 yr
- Director2016 – 2020 · 4 yrNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?